WNY1613 is a potent and selective PI3Kdelta inhibitor with a piperazinone-containing purine scaffold, exhibiting anti-NHL effects both in vitro and in vivo by inhibiting phosphorylation of downstream components of PI3K in NHL cell lines and inducing apoptosis in cancer cells.
Molekulargewicht:
557.65
CAS Nummer:
[2650546-39-5]
Formel:
C29H35N9O3
Target-Kategorie:
PI3K|||Others|||Apoptosis
T63942
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten